Editorial Team

Chief Editor

  1. Yali Friedman, Journal of Commercial Biotechnology

Associate Editors

  1. Arlen Meyers, Professor, Department of Otolaryngology, Dentistry and Engineering, University of Colorado Denver, United States
  2. Jeff Walenta, Office of Technology Transfer, National Institutes of Health, United States
  3. Christian Walker, Director, Military & Veterans Health Institute, Johns Hopkins University

Special Projects and Video Interviews

Editorial Advisory Board

  1. Mark Ahn, Principal, Pukana Partners, Ltd., USA, United States
  2. John Avellanet, Cerulean Associates LLC, United States
  3. Boris Bogdan, Partner, Avance, Basel GmbH, Switzerland
  4. Arthur Boni, John R. Thorne Chair of Entrepreneurship; Distinguished Career Professor; and Director, Donald H. Jones Center for Entrepreneurship, Tepper School of Business, Carnegie Mellon University, United States
  5. Walter Bratic, Managing Director, Overmont Consulting LLC, United States
  6. G. Steven Burrill, Chief Executive Officer, Burrill & Company, United States
  7. Steven Casper, Henry E. Riggs Professor of Management, Keck Graduate Institute of Applied Life Sciences, United States
  8. Ananda Mohan Chakrabarty, University of Illinois at Chicago, United States
  9. Vijay Chandra, Chairman & CEO, Strand Life Sciences Pvt Ltd, India and Consulting Professor, ISL/EE, Stanford University, United States
  10. James Class, Director, Global Public Policy, Merck, United States
  11. Jeremy Laurence Curnock Cook, Executive Chairman, Bioscience Managers Limited, United Kingdom
  12. Iraj Daizadeh, Senior Manager, Amgen Inc, United States
  13. Mitch DeKoven, Director - Reimbursement and Market Access, Health Economics & Outcomes Research, IMS Health, United States
  14. Spencer G. Feldman, Shareholder, Greenberg Traurig, United States
  15. Robert Freeman, Adjunct Professor, South Carolina College of Pharmacy, USC, United States
  16. Sharon Finch, Director, Medius Associates, United Kingdom
  17. Hernan Garrido-Lecca, Chairman and CEO Bioinvest; Professor of Economics and Public Policy, Universidad de San Martín de Porres, Lima Peru and Former Minister of Health, Peru
  18. Gerald S. Graham, Business and Management Consultant, Graham Consulting Group, United States
  19. Dave Jensen, Managing Director, CareerTrax Inc., United States
  20. Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development and Professor of Medicine, Tufts University School of Medicine, United States
  21. John Khong, Owner, Niche Medical, J & M Technologies, Cell Sciences; Adjunct faculty, LKC Business School, Singapore management University, Singapore
  22. Edward L. Korwek, Partner, Hogan Lovells, United States
  23. Thomas J. Kowalski, Attorney at Law, Vedder Price P.C., United States
  24. Leonard Lerer, Sudarskis & Partners, United Arab Emirates
  25. Weijun Li, Senior Research Scientist, Global Biological Development, Bayer HealthCare Pharmaceuticals, United States
  26. Bryan A. Liang, Professor of Anesthesiology & Director San Diego Center for Patient Safety, University of California San Diego School of Medicine; Professor of Law & Executive Director, Institute of Health Law Studies, California Western School of Law, United States
  27. Kate Lynch, CEO, Generic Medicines Industry Association (GMiA), Australia
  28. Barry Marenberg, Chief Intellectual Property Strategist, BJM BioPat Solutions, United States
  29. Henry I. Miller, Senior Research Fellow of Scientific Philosophy & Public Policy, Hoover Institution, Stanford University, United States
  30. Stefan Michael Miller, Associate, Dechert LLP, United States
  31. Sudha Nair, Director, Global Business Development, Apotex Fermentation Inc., Canada
  32. Robin Nott, Chair of the Laws Committee, Licensing Executives Society Britain and Ireland, United Kingdom
  33. Meir Perez Pugatch, Managing Director Pugatch Consilium; Chair, Division of Health Systems Administration, School of Public Health, University of Haifa, Israel
  34. Rebecca Robins, Director, Europe, Business Development, Interbrand Wood Healthcare, United Kingdom
  35. Anthony J Russo, Chairman and CEO, Russo Partners, United States
  36. Stephen M. Sammut, Senior Fellow, Wharton Health Care Systems and Entrepreneurial Programs and Venture Partner, Burrill & Company, United States
  37. Simon Shohet, Practice Director, Pope Woodhead & Associates Ltd, United Kingdom
  38. Grant Skrepenk, Assistant Professor, The University of Arizona College of Pharmacy and Investigator, Center for Health Outcomes and PharmacoEconomic Research, United States
  39. Anthony Stevens, Director, Medical Options, United Kingdom
  40. Philip Neal Sussman, Managing Partner, The Channel Group LLC, United States
  41. Michael Vitale, Director of Commercialisation, Monash Asia-Pacific Centre for Science and Wealth Creation, Monash University, Australia
  42. Stan Yakatan, Chairman, Katan Associates, United States


Copyright © thinkBiotech LLC